October 15, 2007 / 6:44 AM / in 10 years

Solvay sells Caprolactones unit for 200 mln euros

1 Min Read

BRUSSELS, Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden's Perstorp Group.

The transaction is expected to be completed in the fourth quarter of 2007, pending regulatory approvals.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below